Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 21 January 2020 |
| Author/s |
author: Hiroshi Ureshino |
| Publication date | January 21, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |